New Owner
Merck & Co., Inc. - cCAM Biotherapeutics
Merck & Co., Inc. acquires cCAM Biotherapeutics
Announced: July 28, 2015
Type: Acquisition
Terms: Cash
Status: Complete
Amount: $ 95,000,000